Listar por autor "Chase, B. A."
Mostrando ítems 1-4 de 4
-
The Application of Multivariate Model-Building to Derive Predictive Biomarker Signatures in Parkinson's Disease Patients
Gunselman, S. J.; Woodford, T. M.; Bramwell, D. I.; Chase, B. A.; Tsintou, M.; Markopoulou, K. (2010) -
Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease
Markopoulou, K.; Dickson, D. W.; McComb, R. D.; Wszolek, Z. K.; Katechalidou, L.; Avery, L.; Stansbury, M. S.; Chase, B. A. (2008)Individuals with familial Parkinson's disease (PD) due to a monogenic defect can show considerable clinical and neuropathological variability. To identify factors underlying this variability, histopathological analysis was ... -
Olfaction in Parkin-associated Parkinson disease
Markopoulou, K.; Chase, B. A. (2011) -
A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction
Puschmann, A.; Ross, O. A.; Vilarino-Guell, C.; Lincoln, S. J.; Kachergus, J. M.; Cobb, S. A.; Lindquist, S. G.; Nielsen, J. E.; Wszolek, Z. K.; Farrer, M.; Widner, H.; van Westen, D.; Hagerstrom, D.; Markopoulou, K.; Chase, B. A.; Nilsson, K.; Reimer, J.; Nilsson, C. (2009)A de novo alpha-symaclein A53T (p.Ala53 Th; c.209G > A) mutation has been identified in a Swedish family with autosomal dominant Parkinson's disease (PD). Two affected individuals had early-onset (before 31 and 40 years), ...